Saol Therapeutics Inc. (“Saol”) maintains a comprehensive, and effective Corporate Compliance Program (the “Corporate Compliance Program”) in accordance with all applicable federal and state requirements and the “Compliance Program Guidance for Pharmaceutical Manufacturers” published by the Office of Inspector General , U.S. Department of Health and Human Services (the “HHS-OIG Guidance”) and the California Health & Safety Code sections 119400-119402 (SB 1765). Our Corporate Compliance Program reflects our unwavering commitment to the highest standards of corporate conduct and integrity.
Overview of the Comprehensive Compliance Program
The Saol Corporate Compliance Program, described in further detail below, contains policies, procedures and processes to address various compliance risk areas identified in the HHS-OIG Guidance and the Pharmaceutical Research and Manufacturers of America (PhRMA “Code on Interactions with Healthcare Professionals.” (the “PhRMA Code”). As recommended by the HHS-OIG Guidance, the Saol Corporate Compliance Program has been designed to fit the specific compliance needs of the company. Saol will regularly review and evaluate its Corporate Compliance Program to ensure it continues to meet the evolving needs of our company.
Key Elements of the Saol Corporate Compliance program include:
- Appointment of a Chief Corporate Compliance Officer who reports directly to Saol’s Board of Directors
- A Corporate Compliance Committee
- A Sales and Marketing Code of Conduct
- Availability of anonymous reporting option for raising compliance concerns
- The conduct of annual audits to monitor compliance with the Corporate Compliance Program and Sales and Marketing Code of Conduct
- Routine training of employees on the Corporate Compliance Program and Sales and Marketing Code of Conduct
- Reporting transfers of value and payments made to Healthcare Professionals and Healthcare Organizations (“Open Payments”).
Open Payments FAQs: Saol’s Commitment to Transparency with the Healthcare Community
This FAQ is directed to healthcare professionals and serves to answer any questions related to the Open Payments Program and Saol’s responsibilities under it. CMS has a website dedicated to Open Payments which includes its own FAQs and a specific section on information for physicians.
Corporate Compliance Officer and Corporate Compliance Committee
Saol has designated a Corporate Compliance Officer who is charged with the responsibility of developing, implementing, monitoring, and updating the Saol Corporate Compliance Program. The Corporate Compliance Officer has the authority to effectuate change and exercise independent judgment within the company. Additionally, the Corporate Compliance Officer reports directly to the CEO and provides periodic compliance updates to the Board of Directors.
Saol has also established a Corporate Compliance Committee comprised of senior management personnel from a variety of business units. The Corporate Compliance Committee advises and assists the Corporate Compliance Officer in the development, maintenance and updating of the Corporate Compliance Program.
Saol has established written policies and procedures to ensure compliance with the “PhRMA Code” in California, including the Saol Corporate Compliance Program and Sales and Marketing Code of Conduct and other complementary policies that outline the company’s commitment to compliance and corporate accountability. The standards set forth in the policies and procedures apply to all Saol employees, contractors and agents, and adherence to company policies is a condition of employment.
Education and Training
All employees are required to receive compliance training applicable to their job function and responsibilities, which includes training on the Corporate Compliance Program and complementary policies. In addition, further specialized training may be provided where a need for additional training has been identified. Annual compliance training is required of all employees. Saol regularly reviews and updates its training programs to help ensure it continues to meet the educational needs of its employees.
Effective Lines of Communication
Saol is committed to open dialogue between management and employees. Our goal is to foster an open door policy to encourage employees to ask questions or report potential instances of inappropriate activity without fear of retaliation. We have established a confidential and anonymous Compliance Hotline number that is available 24 hours a day, seven days a week for making good faith reports of known or suspected violations.
Auditing and Monitoring
Saol recognizes that a comprehensive auditing and monitoring plan is critical to maintaining the effectiveness of a Corporate Compliance Program. The subject of our auditing and monitoring assessments, as well as the extent and frequency of our reviews, may vary according to a variety of factors, including new regulatory requirements, changes in business practices and other considerations.
Responding to Potential Violations
The purpose of our Corporate Compliance Program is to prevent and detect violations of law or company policy. As the HHS-OIG Guidance recognizes, however, the implementation of such a program cannot guarantee that improper employee conduct will be entirely eliminated. Nonetheless, it is Saol’s expectation that all employees will comply with the Corporate Compliance Program, and the policies established in support of such program. All Saol employees have a duty to promptly report any violation of the Corporate Compliance Program or any company policies using any of the available company resources. In the event that Saol becomes aware of violations of law or company policy, we will promptly investigate the matter and take appropriate corrective action to ensure the integrity of the Corporate Compliance Program and prevent future violations. Personnel who violate Saol’s policies and procedures and applicable state and federal laws may be subject to disciplinary action up to and including termination.
Annual Aggregate Dollar Limit in California
Saol does not permit gifts, promotional materials, items, or activities in California that are prohibited by the PhRMA Code, HHS-OIG Guidance, or FDA regulations. For items and activities that are not prohibited, Saol has set an annual aggregate spending limit of $1,500.00 per healthcare professional, as required by California SB 1765. This amount represents an upper limit rather than a spending goal or a usual, customary or typical amount for medical or healthcare professionals. This limit excludes amounts attributable to drug samples, financial support for continuing medical education, or payment at fair market value for legitimate professional services. In setting this limit, Saol has taken into account the size of the company and its portfolio and will revise this limit as the company and or product portfolio changes.
Saol Declaration of Compliance
Saol declares that, to the best of its knowledge and based on a good faith understanding of the statutory requirements, for the period commencing of January 1, 2021 to December 31, 2021, it is in compliance with its Corporate Compliance Program, including its established annual aggregate spend limit of $1,500.00 and the requirements of California Health and Safety Code sections 119400-119402 (SB 1765).
Saol Therapeutics Inc. is committed to the maintenance and ongoing assessment necessary to ensure an effective Corporate Compliance program. This Corporate Compliance Program may be amended, altered or revised from time to time as needed and without prior notice.
To obtain a printed copy of the Corporate Compliance Program or the Declaration of Compliance please call (770) 274-2490 or email email@example.com.